Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors
Clinical trial NCT06425705 · COMPLETED
Trial details
- NCT number
- NCT06425705
- Sponsor
- Lahore General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-25
- Primary completion
- 2023-07-10
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.